Six Episode Series from Medscape TV - Hepatitis C Virus: Containing the Threat
In the past few years, a new class of direct-acting antiviral agents has made the treatment of HCV easier and more effective than ever before, with cure rates nearing 100%, even among HIV-positive patients. But not all patients with HCV who are eligible for antiviral treatment are identified, and even fewer are being referred for care. Thus, HCV infection remains a significant risk for progression to cirrhosis, liver failure, and hepatocellular carcinoma. Liver specialists at two prestigious Chicago medical centers confront the key issues in the management of patients with chronic HCV infection.
Medscape TV Final Episode
December 11, 2017
EPISODE 6 - Strategies for PreventionPrimary care physicians can help stem the spread of HCV infection through patient education and screening
November 8, 2017
EPISODE 5 - Hepatitis C Virus: Dealing With Chronic Disease
Patients with advanced disease will need help beyond current therapy, including managing comorbidities and navigating transplant.
October 10, 2017
EPISODE 4 - The New Regimens
Liver specialists find that HCV patients who have comorbid conditions and treatment-resistant disease may still be candidates for combination therapies.
August 17, 2017
EPISODE 3 - Hope and Uncertainty
Patients who have not responded to previous HCV therapies often need support to continue therapy and testing, and to maintain health.
Patients with advanced disease will need help beyond current therapy, including managing comorbidities and navigating transplant.
October 10, 2017
EPISODE 4 - The New Regimens
Liver specialists find that HCV patients who have comorbid conditions and treatment-resistant disease may still be candidates for combination therapies.
August 17, 2017
EPISODE 3 - Hope and Uncertainty
Patients who have not responded to previous HCV therapies often need support to continue therapy and testing, and to maintain health.
July 17, 2017
EPISODE 2 - Considerations Before HCV Therapy
Physicians assess such factors as performance status and risk for reinfection to determine whether a patient is a candidate to receive HCV treatments.
EPISODE 2 - Considerations Before HCV Therapy
Physicians assess such factors as performance status and risk for reinfection to determine whether a patient is a candidate to receive HCV treatments.
June 21, 2017
EPISODE 1 - Strides and Obstacles
HCV treatments are highly efficacious, but challenges remain in screening persons at risk of contracting and spreading infection, as well as in the treatment of liver diseases caused by HCV
EPISODE 1 - Strides and Obstacles
HCV treatments are highly efficacious, but challenges remain in screening persons at risk of contracting and spreading infection, as well as in the treatment of liver diseases caused by HCV
No comments:
Post a Comment